Federal Joint Committee (Germany)

Last updated

The Federal Joint Committee (German: Gemeinsamer Bundesausschuss) refers to a group of German public health agencies that were merged in 2004, under an independent chairman. [1] It is authorized to make binding regulations growing out of health reform bills passed by lawmakers, along with routine decisions regarding healthcare in Germany. [1]

Contents

Although the committee is not a subordinate agency and is independent of the Ministry of Health, government officials are responsible for exercising legal supervision over the committee's decisions and guidelines. As a supreme decision-making body, the Committee exerts a direct influence on the healthcare provisions for millions of people. [2]

History

The Federal Joint Committee (G-BA) was formed in 2004 by the merger of the following organizations

These organizations had been created several decades ago[ when? ] to ensure supervision of the professional relationship between doctors and health insurers. Their roots can be partially traced back to the Weimar Republic in the late-1910s and 1920s. [3] In 2004, they were renamed and merged into the Federal Joint Committee (G-BA) as follows:

As a supreme decision-making body, the Joint Committee exerts a direct influence on the healthcare provisions for millions of people. [2]

Decision-making process

In the early stages of the Committee 's decision-making process, assessment reports of diagnostic or therapeutic interventions are prepared by the Institute for Quality and Efficiency in Health Care on behalf of the committee. [5] All resolutions and guidelines passed by the Federal Joint Committee are subsequently audited by the Ministry of Health. [4]

The directives issued by the committee are legally binding for publicly insured persons as well as for the providers and payers of health care. In total, healthcare provisions for 70 million people, excluding those who are privately insured, are determined by the committee. [2]

Notable guidelines

Following the German acupuncture trials from 2002 to 2006, the Committee decided to include acupuncture into the catalogue of services covered by statutory health insurance organizations for the treatment of low back pain and knee pain. [6]

On June 17, 2010, the Committee removed the usage of glinides from general prescription guidelines for the reduction of human glucose levels. It justified its decision by referring to the conclusion of the Institute for Quality and Efficiency in Health Care that proof of efficacy was lacking. [7]

In 2013, the Committee issued a preliminary decision ruling that a fixed dose combination of Stribild does not offer a benefit over Atripla for HIV treatment. [8]

See also

Related Research Articles

Aetna American insurance company

Aetna Inc. is an American managed health care company that sells traditional and consumer directed health care insurance and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans, primarily through employer-paid insurance and benefit programs, and through Medicare. Since November 28, 2018, the company has been a subsidiary of CVS Health.

Financial regulation Rules or restrictions for financial institutions

Financial regulation is a form of regulation or supervision, which subjects financial institutions to certain requirements, restrictions and guidelines, aiming to maintain the stability and integrity of the financial system. This may be handled by either a government or non-government organization. Financial regulation has also influenced the structure of banking sectors by increasing the variety of financial products available. Financial regulation forms one of three legal categories which constitutes the content of financial law, the other two being market practices and case law.

<i>Canada Health Act</i> Canadian federal law for health care funding

The Canada Health Act is a statute of the Parliament of Canada, adopted in 1984, which establishes the framework for federal financial contributions to the provincial and territorial health insurance programs, commonly called "medicare". To receive federal funding, the provinces and territories must comply with the terms of the CHA, which establishes the principle of universal, single-payer healthcare.

Life insurance Type of contract

Life insurance is a contract between an insurance policy holder and an insurer or assurer, where the insurer promises to pay a designated beneficiary a sum of money upon the death of an insured person. Depending on the contract, other events such as terminal illness or critical illness can also trigger payment. The policy holder typically pays a premium, either regularly or as one lump sum. The benefits may include other expenses, such as funeral expenses.

Health insurance or medical insurance is a type of insurance that covers the whole or a part of the risk of a person incurring medical expenses. As with other types of insurance is risk among many individuals. By estimating the overall risk of health risk and health system expenses over the risk pool, an insurer can develop a routine finance structure, such as a monthly premium or payroll tax, to provide the money to pay for the health care benefits specified in the insurance agreement. The benefit is administered by a central organization, such as a government agency, private business, or not-for-profit entity.

The term managed care or managed healthcare is used in the United States to describe a group of activities intended to reduce the cost of providing health care and providing American health insurance while improving the quality of that care. It has become the predominant system of delivering and receiving American health care since its implementation in the early 1980s, and has been largely unaffected by the Affordable Care Act of 2010.

...intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as Health Maintenance Organizations and Preferred Provider Organizations.

Medical guideline Document with the aim of guiding decisions and criteria in healthcare

A medical guideline is a document with the aim of guiding decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare. Such documents have been in use for thousands of years during the entire history of medicine. However, in contrast to previous approaches, which were often based on tradition or authority, modern medical guidelines are based on an examination of current evidence within the paradigm of evidence-based medicine. They usually include summarized consensus statements on best practice in healthcare. A healthcare provider is obliged to know the medical guidelines of his or her profession, and has to decide whether to follow the recommendations of a guideline for an individual treatment.

Healthcare in Switzerland Overview of the health care system in Switzerland

The healthcare in Switzerland is universal and is regulated by the Swiss Federal Law on Health Insurance. There are no free state-provided health services, but private health insurance is compulsory for all persons residing in Switzerland.

Utilization management (UM) or utilization review is the use of managed care techniques such as prior authorization that allow payers, particularly health insurance companies, to manage the cost of health care benefits by assessing its appropriateness before it is provided using evidence-based criteria or guidelines.

Federal Ministry of Health (Germany) Federal ministry of the Federal Republic of Germany

The Federal Ministry of Health, abbreviated BMG, is a cabinet-level ministry of the Federal Republic of Germany. It is the highest German federal government department responsible for health. The ministry is officially located in Bonn and with a second office, which houses the ministry's management, location in Berlin.

Federal Financial Supervisory Authority

The Federal Financial Supervisory Authority better known by its abbreviation BaFin is the financial regulatory authority for Germany. It is an independent federal institution with headquarters in Bonn and Frankfurt and falls under the supervision of the Federal Ministry of Finance. BaFin supervises about 2,700 banks, 800 financial services institutions, and over 700 insurance undertakings.

A Private Health Services Plan in Canada is Health and/or Dental Care, as part of an insured Group Insurance Plan or a self-insured plan, such as a Health Spending Account, Cost-Plus Plan or one of the three options under a Health and Welfare Trust.

German Agency for Quality in Medicine

The German Agency for Quality in Medicine (AEZQ) - in German "Ärztliches Zentrum für Qualität in der Medizin (ÄZQ)", established in 1995 and located in Berlin, co-ordinates healthcare quality programmes with special focus on evidence-based medicine, medical guidelines, patient empowerment, patient safety programs, and quality management.

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen is a bilingual German and English language peer-reviewed medical journal published by Elsevier Germany. It was established in 1904 as the Zeitschrift für ärztliche Fortbildung by Ernst von Bergmann. ZEFQ is the organ of various organisations working in the fields of evidence-based medicine, patient empowerment, patient safety, and quality management in healthcare:. Among these are:

Insurance in the United States refers to the market for risk in the United States, the world's largest insurance market by premium volume. According to Swiss Re, of the $6.287 trillion of global direct premiums written worldwide in 2020, $2.530 trillion (40.3%) were written in the United States.

Healthcare in Germany Overview of healthcare in the Federal Republic of Germany

Germany has a universal multi-payer health care system paid for by a combination of statutory health insurance and private health insurance.

National Association of Statutory Health Insurance Physicians

The National Association of Statutory Health Insurance Physicians (NASHIP) - in German "Kassenärztliche Bundesvereinigung (KBV)", based in Berlin, is the co-ordinating body of all 17 State Associations of Statutory Health Insurance Physicians in Germany. As of 2018, it represented about 175,000 office-based physicians' and psychotherapists in Germany. NASHIP is co-owner of the medical journal Deutsches Ärzteblatt and of the German Agency for Quality in Medicine, a member of the Guidelines International Network - together with the German Medical Association.

German acupuncture trials

The German acupuncture trials were a series of nationwide acupuncture trials set up in 2001 and published in 2006 on behalf of several German statutory health insurance companies because of a dispute as to the usefulness of acupuncture. They consisted of one observational study on acupuncture side effects, and four randomized controlled trials (RCTs) investigating acupuncture treatment for low back pain, knee osteoarthritis, migraine prophylaxis, and tension-type headache. The trials are considered to be one of the largest clinical studies in the field of acupuncture.

Social security in Germany is codified on the Sozialgesetzbuch (SGB), or the "Social Code", contains 12 main parts, including the following,

The Affordable Care Act (ACA) is divided into 10 titles and contains provisions that became effective immediately, 90 days after enactment, and six months after enactment, as well as provisions phased in through to 2020. Below are some of the key provisions of the ACA. For simplicity, the amendments in the Health Care and Education Reconciliation Act of 2010 are integrated into this timeline.

References

  1. 1 2 E. REINHARDT, UWE (2009-07-24). "A German Import That Could Help U.S. Health Reform". The New York Times . Retrieved 25 May 2013. Germany’s joint committee was established in 2004 and authorized to make binding regulations growing out of health reform bills passed by lawmakers, along with routine coverage decisions. The ministry of health reserves the right to review the regulations for final approval or modification. The joint committee has a permanent staff and an independent chairman.
  2. 1 2 3 Fricke, Frank-Ulrich; Dauben, Hans Peter (June 2009). "Health Technology Assessment: A Perspective from Germany". Value in Health. 12: S20–S27. doi: 10.1111/j.1524-4733.2009.00555.x . PMID   19523181. The G-BA is the supreme decision-making body of the so-called self-governing system in Germany. Physicians, dentists, hospitals, sickness funds, and patients are represented in the G-BA. The G-BA issues directives and, thus, determines the benefit package of the SHI covering about 70 million people. Finally, the G-BA is responsible for reimbursement decisions.
  3. 1 2 3 4 5 Kälble, Bernhard Borgetto ; Karl (2007). Medizinsoziologie : sozialer Wandel, Krankheit, Gesundheit und das Gesundheitssystem (in German). Weinheim: Juventa-Verl. p. 184. ISBN   9783779914846.
  4. 1 2 3 4 "The Federal Joint Committee: Who we are and what we do". Gemeinsamer Bundesausschuss. Retrieved 25 May 2013.
  5. Wieseler, B.; McGauran, N.; Kaiser, T. (12 October 2010). "Finding studies on reboxetine: a tale of hide and seek". BMJ . 341: c4942. doi:10.1136/bmj.c4942. PMID   20940211. Produces health technology assessments on diagnostic or therapeutic interventions and health economic evaluations for the Federal Joint Committee (G-BA)—the statutory health insurance system’s main decision making body
  6. Karin Hertzer (August 12, 2009). "Akupunktur ist wirksam". Focus (German magazine) (in German). Der Gemeinsame Bundesausschuss der Ärzte und Krankenkassen entschied dann im April 2006, die Akupunktur als Kassenleistung gegen Rücken- und Knieschmerzen anzuerkennen.
  7. Kreis, J; Busse, R (January 2012). "From evidence assessments to coverage decisions?: the case example of glinides in Germany". Health Policy (Amsterdam, Netherlands). 104 (1): 27–31. doi:10.1016/j.healthpol.2011.11.006. PMID   22136812.
  8. Ed Silverma (2013-09-18). "Will German Regulators Dampen Gilead Hopes For Its Stribild AIDS Drug?". Forbes . Retrieved 20 November 2013.